Indonesia to roll out vaccine next year Some other nations also consider approving it "Qdenga" is yet to receive WHO approval In market, Sanofi's Dengvaxia is lone approved shot After years of research, Japan's pharmaceutical giant Takeda Pharmaceutical Company has developed a dengue vaccine named "Qdenga" – offering hope for future generations.
After decades of delays, the first vaccine for dengue fever was introduced seven years ago. But that formula, from Sanofi, was soon found to be suitable only for people who had previously been infected with the disease, spurring researchers at Japan's Takeda Pharmaceutical Co. to redouble efforts on an alternative. That work is finally paying off, with their version expected